Breaking News
Get 40% Off 0
June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date. Unlock Stocks
Close

Aurobindo Pharma Ltd. (ARBN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,230.00 +44.30    +3.74%
05:59:59 - Closed. Currency in INR ( Disclaimer )
  • Volume: 1,781,687
  • Bid/Ask: 1,223.15 / 1,230.00
  • Day's Range: 1,205.55 - 1,230.00
Type:  Equity
Market:  India
ISIN:  INE406A01037 
S/N:  AUROPHARMA
Aurobindo Pharma 1,230.00 +44.30 +3.74%

ARBN Balance Sheet

 
Featured here, the Balance Sheet for Aurobindo Pharma Ltd., which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 242056.3 - 235551.5 -
Cash and Short Term Investments 63288.8 71490.2 71490.2 62327.1
Cash - - - -
Cash & Equivalents 62783 - 70715.6 -
Short Term Investments 505.8 - 774.6 -
Total Receivables, Net 48296 - 46528.4 -
Accounts Receivables - Trade, Net 48167.4 - 46395.8 -
Total Inventory 98082.3 - 92823.3 -
Prepaid Expenses - - - -
Other Current Assets, Total 32389.2 - 24709.6 -
Total Assets 450715.1 - 439235.9 -
Property/Plant/Equipment, Total - Net 142849 - 136683 -
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 5951.5 - 5929 -
Intangibles, Net 34814.6 - 32412.6 -
Long Term Investments 3216.5 - 3572.6 -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 9642.5 - 15194.4 -
Other Assets, Total 94994.6 - 81804.5 -
Total Current Liabilities 121991.3 - 130119.7 -
Accounts Payable 44541.6 - 45053.9 -
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 42602 - 46186.6 -
Other Current liabilities, Total 34847.7 - 38879.2 -
Total Liabilities 152207.1 - 157290.8 -
Total Long Term Debt 23874.3 - 20299.7 -
Long Term Debt 21349 - 17082.8 -
Capital Lease Obligations 2525.3 - 3216.9 -
Deferred Income Tax 3565.6 - 4307.9 -
Minority Interest 80 - 57.1 -
Other Liabilities, Total 2695.9 - 2506.4 -
Total Equity 298508 281945.1 281945.1 268518.5
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 585.9 - 585.9 -
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) - - - -
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 297922.1 281945.1 281359.2 268518.5
Total Liabilities & Shareholders' Equity 450715.1 - 439235.9 -
Total Common Shares Outstanding 585.91 583.72 590.16 585.99
Total Preferred Shares Outstanding - - - -
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARBN Comments

Write your thoughts about Aurobindo Pharma Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email